Structured evidence table for Resveratrol Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Blood Pressure Randomized Trial | Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials. | 1 | Sun JN (2026) | Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials. |
| Resveratrol Blood Pressure Randomized Trial | Background/aim Resveratrol, a polyphenolic compound found in grapes, berries, and peanuts, has been linked to antioxidant, anti-inflammatory, and vasoprotective effects. | 4 | Shen CY (2026) | Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases. |
| Resveratrol Blood Pressure Randomized Trial | Yet, evidence from randomized controlled trials (RCTs) remains inconsistent, and the quality, dosage, and cost of commercial resveratrol products vary considerably, raising uncertainty about their true efficacy. | 4 | Shen CY (2026) | Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases. |
| Resveratrol Blood Pressure Randomized Trial | Materials and methods We systematically searched PubMed, Embase, the Cochrane Library, and Web of Science for RCTs published up to July 2025 that evaluated resveratrol supplementation in adults with obesity-related metabolic disorders or associated risk factors. | 4 | Shen CY (2026) | Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases. |
Source documents